← Back

CLASSYS Inc

CLASSYS Inc. provides medical aesthetics devices worldwide. Its product lineup includes ULTRAFORMER MPT, ULTRAFORMER III, VOLNEWMER, Secret RF, Secret PRO, Secret DUO, Fortra, SCIZER, CLATUU Alpha, Ulfit, Refit, AQUAPURE, FORSHAPE, INTRASURE, AQUAPURE II, Reepot, veloce, Pento, and curas hybrid laser system. The company also sells cosmetics under the Classys, Cluederm, and Skederm brands. It serves distributors, clinics, hospitals, and direct end users. Founded in 2007 and headquartered in Seoul, South Korea, CLASSYS Inc. is a subsidiary of BCPE Centur Investments, LP.

Country
Price · split & dividend adjusted
News & notes moving 214150.KQ
214150.KQ

Classys Expects Global Device Sales to Surpass 50,000 Units This Year

Classys Inc. expects its worldwide device sales to surpass 50,000 units this year. As of the end of June, the company had a cumulative global installed base of more than 22,000 units for its flagship HIFU line and more than 4,000 units for its MRF line, while its MNRF and dermabrasion product lines have each surpassed 6,000 cumulative global installations. Classys reported consolidated revenue of KRW 192.7 billion for the first half of the year, a 20% year-over-year increase, and consumables revenue reached KRW 80.2 billion, up 5.3% year over year and 52.7% from the first half of 2024. The company plans to leverage its established footprint to introduce next-generation platforms and create additional growth through the global rollout of Quadessy and the planned European launch of Viclara later this year.
PR Newswire·25dRead more →
214150.KQ

CLASSYS Appoints Former Samsung Executive Dr. Taek-Soo Kim as Chief Technology Officer

CLASSYS has appointed Dr. Taek-Soo Kim, a former Samsung Electronics and Vuno executive, as its new Chief Technology Officer and Head of Research and Development. The appointment follows last month's hiring of Jun-oh Yoon, former Executive Vice President of Samsung Electronics, as CEO, as part of the company's Next Stage growth strategy. Dr. Kim will focus on integrating CLASSYS's energy-based device technologies with clinical data and AI to develop next-generation products, while incorporating feedback from clinicians and key opinion leaders across global markets. His experience leading large-scale R&D transformation at Samsung Advanced Institute of Technology is expected to accelerate the implementation of global-standard management systems within the R&D organization.
PR Newswire·43dRead more →
214150.KQ

CLASSYS Appoints Former Samsung and Vuno Executive Dr. Taek-Soo Kim as CTO

CLASSYS has appointed Dr. Taek-Soo Kim, a former executive at Samsung Electronics and Vuno, as its new Chief Technology Officer and Head of Research and Development. The move is part of the company's "Next Stage" growth strategy under CEO Jun-oh Yoon, aiming to accelerate development of next-generation products integrating AI, software, and data. Dr. Kim holds a Ph.D. in Electrical Engineering from Stanford University and brings over 20 years of experience in technology strategy and R&D innovation from roles at Boston Consulting Group, Samsung Advanced Institute of Technology, and Vuno. His appointment is seen as a key step toward CEO Yoon's vision of transforming CLASSYS into a global medical aesthetics technology platform company with $1 billion in revenue by 2030.
PR Newswire·43dRead more →
214150.KQ2

CLASSYS Appoints Former Samsung Electronics Executive Vice President Jun-oh Yoon as CEO

CLASSYS has appointed Jun-oh Yoon, former Executive Vice President of Samsung Electronics, as its new Chief Executive Officer to lead the company's next stage of global growth. Yoon brings extensive leadership experience from Samsung Group and Samsung Electronics, where he played a key role in corporate strategy, global M&A, and value creation, including spearheading the acquisition of Harman and serving on the boards of Rainbow Robotics and FläktGroup. Under his leadership, CLASSYS will focus on accelerating global expansion, advancing AI-powered next-generation products, optimizing its business portfolio, and strengthening management systems. The company, which generates approximately 67% of its revenue from overseas markets, aims to become the world's leading medical aesthetics platform company by 2030.
PR Newswire·65dRead more →